In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...
September 13, 2010 (Geneva, Switzerland) — Three-year results for the landmark SYNTAX trial are bringing some clarity to a finding just hinted at--then strenuously debated--at the two-year mark: ...
The extent and severity of disease, as assessed by Syntax score, strongly correlates with the risk of stent thrombosis at 30 days and 1 year in patients with non-ST-segment elevation acute coronary ...
Please provide your email address to receive an email when new articles are posted on . At 5 years, elevated rates of major CV events were found in patients with diabetes and stable ischemic heart ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- With ...
BARCELONA — Final, five-year results from the SYNTAX trial comparing CABG surgery and PCI with a drug-eluting stent (DES) in patients with complex coronary disease confirm the message that started to ...
The SYNTAX score is an anatomical-based tool that has quickly become established for long-term risk prediction after percutaneous coronary intervention (PCI). Since publication of the SYNTAX trial, Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback